EFFECTIVENESS AND SAFETY OF INFLIXIMAB AND GOLIMUMAB IN ANKYLOSING SPONDYLITIS FROM A LONGITUDINAL OBSERVATIONAL REGISTRY

被引:0
|
作者
Rahman, Proton [1 ]
Haaland, Derek [2 ]
Sholter, Dalton [3 ]
Starr, Michael [4 ]
Karasik, Artthur
Teo, Michelle
Dixit, Sanjay [5 ]
Masetto, Ariel [6 ]
Jarosynska, Anna
Boulos, Pauline
Rampakakis, Emmanouil [7 ]
Asin-Milan, Odalis [8 ]
Lehman, Allen J. [8 ]
Nantel, Francois [8 ]
机构
[1] Mem Univ, St John, NF, Canada
[2] Waterside Clin, Barrie, ON, Canada
[3] Rheumatol Res Assoc, Edmonton, AB, Canada
[4] McGill Univ, Montreal, PQ, Canada
[5] Arthrit Ctr, Burlington, ON, Canada
[6] Ctr Hosp Univ Sherbrooke, Sherbrooke, PQ, Canada
[7] JSS Med Res, Montreal, PQ, Canada
[8] Janssen Inc, Toronto, ON, Canada
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
101
引用
收藏
页码:S63 / S63
页数:1
相关论文
共 50 条
  • [41] Effectiveness and safety of secukinumab in ankylosing spondylitis: real-life data from Midlands Ankylosing Spondylitis Collaboration (MASC)
    Ajibade, Adeola
    Pandian, Haridha
    Jain, Nibha
    Gupta, Latika
    Laxminarayan, Ramasharan
    Moorthy, Arumugam
    Amarasena, Roshan
    Cox, Natasha
    Sapkota, Hem
    Kakade, Girish
    Elamanchi, Srinivasa
    Prabu, Athiveeraramapandian
    Al-Samaraaie, Elaf
    Barkham, Nick
    RHEUMATOLOGY ADVANCES IN PRACTICE, 2022, 7 (01)
  • [42] VALIDATION OF THE ANKYLOSING SPONDYLITIS DISEASE ACTIVITY SCORE (ASDAS) AND EFFECTIVENESS OF INFLIXIMAB IN THE TREATMENT OF ANKYLOSING SPONDYLITIS OVER 4 YEARS
    Rahman, P.
    Choquette, D.
    Khraishi, M.
    Bensen, W.
    Shaikh, S.
    Sholter, D.
    Sheriff, M.
    Rampakakis, E.
    Sampalis, J. S.
    Nantel, F.
    Otawa, S.
    Lehman, A.
    Shawi, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 725 - 725
  • [43] VALIDATION OF THE ANKYLOSING SPONDYLITIS DISEASE ACTIVITY SCORE (ASDAS) AND EFFECTIVENESS OF INFLIXIMAB IN THE TREATMENT OF ANKYLOSING SPONDYLITIS OVER 4 YEARS
    Rahman, P.
    Choquette, D.
    Khraishi, M.
    Bensen, W. G.
    Shaikh, S. A.
    Sholter, D.
    Sheriff, M.
    Rampakakis, E.
    Sampalis, J. S.
    Nantel, F.
    Otawa, S.
    Lehman, A. J.
    Shawi, M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (05) : 828 - 829
  • [44] Efficacy of infliximab in subgroups of patients with ankylosing spondylitis: Results from the ankylosing spondylitis study for the evaluation of recombinant infliximab therapy (ASSERT)
    Braun, J
    Maksymowych, WP
    Dougados, M
    Steinfeld, S
    Dewoody, K
    Williamson, P
    Van der Heijde, D
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 402 - 402
  • [45] Long-term efficacy and safety of infliximab treatment of ankylosing spondylitis
    Boeger, CA
    Wittwer, H
    Schattenkirchner, M
    Kellner, M
    JOURNAL OF RHEUMATOLOGY, 2001, 28 : 64 - 64
  • [46] Long-term safety and efficacy of infliximab for the treatment of ankylosing spondylitis
    Elalouf, Ofir
    Elkayam, Ori
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2015, 11 : 1719 - 1726
  • [47] Two year maintenance of efficacy and safety of infliximab in the treatment of ankylosing spondylitis
    Braun, J
    Brandt, J
    Listing, J
    Zink, A
    Alten, R
    Burmester, G
    Gromnica-Ihle, E
    Kellner, H
    Schneider, M
    Sörensen, H
    Zeidler, H
    Sieper, J
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (02) : 229 - 234
  • [48] EFFICACY AND SAFETY OF INFLIXIMAB IN JUVENILE IDIOPATHIC ARTHRITIS AND JUVENILE ANKYLOSING SPONDYLITIS
    Zeng, H.
    Zeng, P.
    Tang, Y.
    Wang, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 239 - 239
  • [49] PREDICTORS OF EMPLOYMENT LOSS IN ANKYLOSING SPONDYLITIS: RESULTS FROM THE SCOTLAND REGISTRY FOR ANKYLOSING SPONDYLITIS
    Dean, Linda E.
    Macfarlane, Gary J.
    Pathan, Ejaz
    Jones, Gareth T.
    RHEUMATOLOGY, 2016, 55 : 75 - 76
  • [50] THE NATURAL HISTORY OF ANKYLOSING SPONDYLITIS: RESULTS FROM THE SCOTLAND AND Ireland REGISTRY FOR ANKYLOSING SPONDYLITIS
    Dean, Linda E.
    Macfarlane, Gary J.
    MacDonald, Alan G.
    Jones, Gareth T.
    RHEUMATOLOGY, 2014, 53 : 143 - 144